潤建股份(002929.SZ):中標中國鐵塔雲南省分公司2022-2024年綜合代維項目
格隆匯11月23日丨潤建股份(002929.SZ)公佈,中國鐵塔在線商務平台近日發佈了《中國鐵塔股份有限公司雲南省分公司2022-2024年綜合代維項目中選候選人結果公示》,潤建股份有限公司為上述項目中標候選人,中標金額合計1.1998億元(含税)。
項目服務內容:為中國鐵塔股份有限公司雲南省分公司2022-2024年提供基礎通信設施綜合運維服務,包括但不限於故障處理、現場巡檢、發電保障、上站配合、設施修理、工程驗收、安全保障、維護資料管理、站址服務管理、按次發電服務、聯合監控值班以及突發事件的應急通信保障等。服務年度:2022年-2024年度。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.